Development of a Core Outcome Set for Dysphagia Interventions in Parkinson's disease (COS-DIP): study protocol

被引:2
|
作者
Hirschwald, Julia [1 ]
Duncan, Sallyanne [2 ]
Warnecke, Tobias [3 ]
Boyle, Gary [1 ]
Regan, Julie [1 ]
Walshe, Margaret [1 ]
机构
[1] Trinity Coll Dublin, Clin Speech & Language Studies, Dublin, Ireland
[2] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland
[3] Univ Hosp Osnabruck, Dept Neurol & Neurorehabil, Osnabruck, Germany
来源
BMJ OPEN | 2024年 / 14卷 / 02期
关键词
Parkinson-s disease; REHABILITATION MEDICINE; Clinical trials; OROPHARYNGEAL DYSPHAGIA; PREVALENCE;
D O I
10.1136/bmjopen-2023-076350
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Current clinical trials on swallowing disorders (dysphagia) in Parkinson's disease (PD) apply a high variety of outcomes and different outcome measures making comparative effectiveness research challenging. Furthermore, views of patients and dysphagia clinicians when selecting trial outcomes have not been considered in the past, thus study results may have little importance to them. This study aims to develop an agreed standardised Core Outcome Set for Dysphagia Interventions in Parkinson's disease (COS-DIP), systematically measured and reported as a minimum for all clinical trials. It will also comprise guidance on outcome definitions, outcome measures and time points of measurement.Methods and analysis The COS-DIP development will comprise five stages following established methodology: (1) a recent scoping review on all applied outcomes, their definitions, methods and time points of measurement in clinical trials in dysphagia in PD, (2) online surveys and focus groups with clinicians, patients, caregivers and family members to identify outcomes that are important to them, (3) an identified list of outcomes based on results of stage 1 and 2, (4) three round online Delphi survey with up to 200 key stakeholders to determine core outcomes and (5) two online consensus meetings with up to 40 representative key stakeholders to agree on all outcomes, definitions, methods and time points of measurement in the final COS-DIP.Ethics and dissemination Full ethical approval was obtained from the Research Ethics Committee, School of Linguistic, Speech and Communication Sciences, Trinity College Dublin, on 15 May 2023 (HT27). Dissemination of the COS-DIP will be enhanced through presentations at (inter-) national conferences and through peer-reviewed, open access publications of related manuscripts. Lay and professional information sheets and infographics will be circulated through relevant patient and professional organisations and networks.Trial registration number The COS-DIP study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database on 24 September 2021 (www.comet-initiative.org/Studies/Details/1942).
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Developing a Neonatal Pulmonary Hypertension Core Outcome Set (NeoPH COS)-A Study Protocol
    Morgan, Cara Ellen
    Woolfall, Kerry
    Aikman, Natasharazia
    Gale, Crhistopher
    Subhedar, Nimish
    RePHyNe Consortium
    PULMONARY CIRCULATION, 2025, 15 (01)
  • [22] The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set
    Richardson, Ebony
    McEwen, Alison
    Newton-John, Toby
    Manera, Karine
    Jacobs, Chris
    TRIALS, 2021, 22 (01)
  • [23] The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set
    Ebony Richardson
    Alison McEwen
    Toby Newton-John
    Karine Manera
    Chris Jacobs
    Trials, 22
  • [24] Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol
    D'Souza, Rohan
    Hall, Chelsea
    Sermer, Mathew
    Siu, Samuel
    Silversides, Candice
    TRIALS, 2020, 21 (01)
  • [25] Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol
    Rohan D’Souza
    Chelsea Hall
    Mathew Sermer
    Samuel Siu
    Candice Silversides
    Trials, 21
  • [26] Development of a core outcome set (COS) for studies relating to awareness and clinical management of reduced fetal movement: study protocol
    Dexter J. L. Hayes
    Declan Devane
    Jo C. Dumville
    Valerie Smith
    Tanya Walsh
    Alexander E. P. Heazell
    Trials, 22
  • [27] Development of a core outcome set (COS) for studies relating to awareness and clinical management of reduced fetal movement: study protocol
    Hayes, Dexter J. L.
    Devane, Declan
    Dumville, Jo C.
    Smith, Valerie
    Walsh, Tanya
    Heazell, Alexander E. P.
    TRIALS, 2021, 22 (01)
  • [28] Study protocol: a core outcome set for perinatal interventions for congenital diaphragmatic hernia
    Simen Vergote
    Felix De Bie
    Jan Bosteels
    Holly Hedrick
    James Duffy
    Beverley Power
    Alexandra Benachi
    Paolo De Coppi
    Caraciolo Fernandes
    Kevin Lally
    Irwin Reiss
    Jan Deprest
    Trials, 22
  • [29] Study protocol: a core outcome set for perinatal interventions for congenital diaphragmatic hernia
    Vergote, Simen
    De Bie, Felix
    Bosteels, Jan
    Hedrick, Holly
    Duffy, James
    Power, Beverley
    Benachi, Alexandra
    De Coppi, Paolo
    Fernandes, Caraciolo
    Lally, Kevin
    Reiss, Irwin
    Deprest, Jan
    TRIALS, 2021, 22 (01)
  • [30] Development of a core outcome set and core measurement set for kangaroo mother care: a study protocol
    Li, Ying Xin
    Li, Yuan
    Li, Xia
    Peng, Han Mei
    Guo, Xue Mei
    Chen, Qiong
    Li, Xiao Wen
    Hu, Yan Ling
    Wan, Xing Li
    BMJ OPEN, 2025, 15 (01):